| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 12/20/2007 | US20070293513 Cristalline and amorphous form of a triazolo (4,5-d) pyridimine compound |
| 12/20/2007 | US20070293511 Crf Receptor Antagonists and Methods |
| 12/20/2007 | US20070293500 Quinazoline derivatives as medicaments |
| 12/20/2007 | US20070293456 Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds |
| 12/20/2007 | US20070292430 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
| 12/19/2007 | EP1867649A1 Piperidyl-2, 6-dione derivatives used to inhibit cells from releasing tumor necrosis factor |
| 12/19/2007 | EP1866314A1 Novel diazabicyclic aryl derivatives and their medical use |
| 12/19/2007 | EP1866313A1 Hiv integrase inhibitors |
| 12/19/2007 | EP1866312A1 Cyclic iminopeptide derivatives |
| 12/19/2007 | EP1866292A1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments |
| 12/19/2007 | EP1865963A2 Triazadibenzoazulene compounds useful for the treatment and prevention of pain and screening methods therefor |
| 12/19/2007 | EP1865959A2 Process for preparing pyridoý2,3-d¨pyrimidin-7-one and 3,4-dihydropyrimidoý4,5-d¨pyrimidin-2(1h)-one derivatives |
| 12/19/2007 | EP1781656B1 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 12/19/2007 | EP1771450B1 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase |
| 12/19/2007 | EP1697372B1 Pyrazolopyrimidines |
| 12/19/2007 | EP1594869B1 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 12/19/2007 | EP1592426B1 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof |
| 12/19/2007 | CN101090902A Cgrp受体拮抗剂 Cgrp receptor antagonists |
| 12/19/2007 | CN101090885A Lactams as comformationally constrained peptidomimetic inhibitors |
| 12/19/2007 | CN101089000A Spiro piperazine quaternary ammonium salt compound and its prepn and application |
| 12/19/2007 | CN100355755C Diazabicyclic central nervous system active agents |
| 12/19/2007 | CN100355754C 7-alkinylamino-triazolopyrimidines, methods for the production and use thereof to combat harmful fungi and agents containing said compounds. |
| 12/19/2007 | CN100355724C Multidentate ligand, polynuclear metal complex, metal complex chain, metal complex assembly and production thereof |
| 12/18/2007 | US7309787 2-Substituted spiro[cyclopropane-1,3'-indolin-2'-ones]: morpholinylphenyl-, piperidinylethylphenyl-, 3-(carboxyethyl)-4-methylpyrrol-2-yl-, pyrazolon-2-yl-, 4-methylimidazol-5-yl-; vascular endothelial growth factor inhibitors; regulate, modulate and/or inhibit abnormal cell proliferation |
| 12/18/2007 | US7309705 7-carboxamido- or sulfonamido-substituted: 2-Phenyl-3-cyclopropyl-7-(4-pyridylcarboxamido)pyrazolo[1.5a]pyrimidine; anticarcinogenic, antiinflammatory, neurodegenerative agent; arthritis, Alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases; with other active compounds |
| 12/18/2007 | US7309700 Crystalline dihydrate is more resistant to heat and humidity than the trihydrate; storage stability |
| 12/18/2007 | US7309699 Such as 4'-(1-azabicyclo[2.2.2]oct-3-yloxy)-1,1'-biphenyl-3-amine; nicotinic acetylcholine receptor modulators; for treatment of attention deficit disorder, Alzheimer*s disease, or AIDS |
| 12/13/2007 | WO2007143521A1 Cyclopropyl fused indolobenzazepine hcv inhibitors |
| 12/13/2007 | WO2007142577A1 Pyrrolo[3,2-d]pyrimidin-4-one derivative as myeloperoxidase inhibitor |
| 12/13/2007 | WO2007142502A1 Method for the synthesis of soluble melanin from precursor amino acids |
| 12/13/2007 | WO2007142216A1 Organic electroluminescent device and material for organic electroluminescent device |
| 12/13/2007 | WO2007142132A1 Novel process for production of compound between porphyrin (y) and polyvalent metal |
| 12/13/2007 | WO2007141805A2 Novel process for the preparation of sildenafil citrate |
| 12/13/2007 | WO2007127763A3 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 12/13/2007 | WO2007109251A3 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases |
| 12/13/2007 | WO2007064797A3 Inhibitors of c-met and uses thereof |
| 12/13/2007 | WO2006110298A3 8-alkyl/aryl-4-aryl-2-n- (alkylamino)-n'-substituted-n'-cyanoguanidino-8h-pyrido[2,3-d]pyrimidin-7-one compounds and use thereof |
| 12/13/2007 | US20070287836 Method for Preparing Compounds Comprising Cucurbituril Groups |
| 12/13/2007 | US20070287829 Preparation of metallotexaphyrins |
| 12/13/2007 | US20070287825 Constrained cis-diol-borate bioconjugation system |
| 12/13/2007 | US20070287705 Crf Receptor Antagonists and Methods Relating Thereto |
| 12/13/2007 | US20070287700 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 12/13/2007 | US20070287694 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors |
| 12/13/2007 | US20070287084 Light Sensitive Organic Photoconductor |
| 12/12/2007 | EP1864986A1 Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof |
| 12/12/2007 | EP1863819A2 Diazabicyclic aryl derivatives and their use as chinolinergic ligands at the nicotinic acetylcholine receptors |
| 12/12/2007 | EP1863818A1 Acetylenyl-pyrazolo-pvrimidine derivatives as mglur2 antagonists |
| 12/12/2007 | EP1863817A1 Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicaments |
| 12/12/2007 | EP1863812A1 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| 12/12/2007 | EP1863774A2 Heterocyclical chromophore architectures with novel electronic acceptor systems |
| 12/12/2007 | EP1863766A2 Certain substituted amides, method of making, and method of use thereof |
| 12/12/2007 | EP1660500B1 Substituted imidazopyrimidines for the prevention and treatment of cancer |
| 12/12/2007 | EP1492794B1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
| 12/12/2007 | EP1268481B1 Kinase inhibitors as therapeutic agents |
| 12/12/2007 | CN101087792A Synthetic process for preparing dual loop compound |
| 12/12/2007 | CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 12/12/2007 | CN101087610A Arylpiperazine derivatives and use thereof as 5-HTLA receptor ligands |
| 12/12/2007 | CN101085777A Method for producing sheep blood hemachrome |
| 12/12/2007 | CN101085776A Method for synthesizing glycoluril dimer |
| 12/12/2007 | CN101085775A 培美曲塞中间体及制备方法 Pemetrexed intermediates and preparation methods |
| 12/12/2007 | CN100354277C 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 12/12/2007 | CN100354276C Biologically active compounds |
| 12/12/2007 | CN100354268C Novel triazolo pyrimidine compounds |
| 12/11/2007 | US7307172 7-amino triazolopyrimidines for controlling harmful fungi |
| 12/11/2007 | US7307165 Process for producting imidazo[1,2-b]pyridazine derivative |
| 12/11/2007 | US7307164 β-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/11/2007 | US7307088 Substituted anthranilic amide derivatives and methods of use |
| 12/11/2007 | US7307087 Antidepressants; analgesics; antiinflammatory agents; side effect reduction |
| 12/11/2007 | US7307082 Heterocyclic derivatives as CRF antagonists |
| 12/11/2007 | CA2413510C Condensed pyrazindione derivatives |
| 12/06/2007 | WO2007140254A2 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 12/06/2007 | WO2007140109A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 12/06/2007 | WO2007139992A2 ALDOSTERONE SYNTHASE AND/OR 11β-HYDROXYLASE INHIBITORS |
| 12/06/2007 | WO2007139860A2 Heterobicylic metalloprotease inhibitors |
| 12/06/2007 | WO2007139856A2 Heterobicyclic metalloprotease inhibitors |
| 12/06/2007 | WO2007139732A1 Pyrazolo [1, 5-a] pyrimidines as cdk inhibitors |
| 12/06/2007 | WO2007139346A1 Composition for induction or inhibition of stem cell differentiation |
| 12/06/2007 | WO2007139240A1 7-(3,4-dialkoxyphenyl)-pyrazolo[1,5-a]pyrimidine compounds, process for preparing thereof, and pharmaceutical composition for treating or preventing asthma, chronic obstructive pulmonary disease, arthritis, atopic dermatitis, tumor and degenerative brain diseases comprising the same |
| 12/06/2007 | WO2007138472A2 Triazolopyridazine derivatives |
| 12/06/2007 | WO2007138355A1 Pyrrolo[1,2-a]pyrazin-1(2h)-one and pyrrolo[1,2-d][1,2,4]triazin-1(2h)-one derivatives as inhibitors of poly(adp-ribose)polymerase(parp) |
| 12/06/2007 | WO2007138072A2 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
| 12/06/2007 | WO2007137793A1 Dihydro-pyrrolopyridine-, dihydro-pyrrolopyridazine- and dihydro-pyrrolopyrimidine-derivatives and use thereof |
| 12/06/2007 | WO2007137785A2 Process useful in the preparation of morphinan antagonists |
| 12/06/2007 | WO2007137782A1 Process for the demethylat i on of oxycodone and related compounds |
| 12/06/2007 | WO2007109456A3 Substituted biphenyl isoxazole sulfonamides as dual angiotensin endothelin receptor antagonists |
| 12/06/2007 | WO2007087150A3 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 12/06/2007 | WO2007075872A3 Nitroimidazole compounds |
| 12/06/2007 | WO2007061737A3 FUSED BICYCLIC mTOR INHIBITORS |
| 12/06/2007 | WO2005069865A3 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases |
| 12/06/2007 | US20070281950 1-((6-chloropyridin-3-yl)methyl)-8-nitro-1,2,3,5,6,7-hexahydro imidazo[1,2-a]pyridin-5-ol; 1-((6-chloropyridin-3-yl)methyl)-5-methoxy-8-nitro-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridine; increased photostability and liposolubility |
| 12/06/2007 | US20070281949 such as 3-(2-Cyclopentyl-2H-pyrazolo[3,4-d]pyrimidin-4-yl)-2-oxo-2,3-dihydro-1H-indole-5-carbonitrile, use in the treatment of neurodegenerative diseases, neurotraumatic diseases, depression and/or diabetes |
| 12/06/2007 | US20070281943 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| 12/06/2007 | US20070281942 Glucokinase activators |
| 12/06/2007 | US20070281941 Dihydrogenphosphate salt of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3- alpha ]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine; diabetes, obesity, and high blood pressure |
| 12/06/2007 | US20070281918 Pyridoazepine derivatives |
| 12/06/2007 | US20070281915 Porphyrin Derivatives and Their Use in Photodynamic Therapy |
| 12/06/2007 | US20070281907 Kinase Inhibitor Phosphonate Conjugates |
| 12/06/2007 | US20070281363 Luminescent compounds |
| 12/06/2007 | US20070280971 Phosphodiesterase type IV (PDE4) inhibitor; 4-{[1-(aminocarbonyl)-4-piperidinyl]amino}-N-[(3,4-dimethylphenyl)methyl]-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide; inflammatory and/or allergic diseases such as atopic dermatitis |
| 12/06/2007 | DE102006025318A1 Dihydro-pyrrolopyridin-, Dihydro-pyrrolopyridazin- und Dihydro-pyrrolopyrimidin-Derivate und ihre Verwendung Dihydro-pyrrolopyridin-, dihydro-pyrrolopyridazin- and dihydro-pyrrolopyrimidine derivatives and their use |